Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies

NCT01554371 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Tumour
Breast Cancer Nos Metastatic Recurrent
Neuropathy

Interventions

DRUG: Eribulin
DRUG: Cyclophosphamide

Sponsor

University of California, San Francisco

Collaborators

[object Object]